3.3 Hypovolemic & Hemorrhagic Shock Fluid Protocols
Key Takeaways
The American College of Surgeons (ACS) ATLS classification categorizes hemorrhagic shock into Classes I through IV based on blood loss volume, heart rate, blood pressure, pulse pressure, urine output, and base deficit.
Damage Control Resuscitation (DCR) prioritizes permissive hypotension (target SBP 80–90 mmHg or MAP 50–60 mmHg) to prevent disrupting nascent clots, but this strategy is strictly contraindicated in traumatic brain injury (TBI), where target SBP must remain ≥100–110 mmHg.
Massive Transfusion Protocols (MTP) mandate a balanced 1:1:1 ratio of packed red blood cells, fresh frozen plasma, and platelets, which was shown in the PROPPR trial to achieve earlier hemostasis and significantly reduce 24-hour mortality from exsanguination.
Tranexamic acid (TXA; 1 g IV over 10 min followed by 1 g IV over 8 hours) significantly reduces all-cause mortality when administered within 3 hours of trauma injury (CRASH-2 trial); administration beyond 3 hours is associated with increased bleeding mortality.
Massive transfusion induces citrate toxicity that rapidly chelates serum ionized calcium; clinicians must administer 1–2 g IV calcium chloride (or 3 g calcium gluconate) for every 4 units of blood products to maintain ionized calcium >1.1–1.2 mmol/L.
Hypovolemic & Hemorrhagic Shock Fluid Protocols
Staging of Hemorrhagic Shock and Non-Hemorrhagic Hypovolemia
Hypovolemic shock results from a critical decrease in intravascular volume, leading to reduced venous return (preload), decreased stroke volume, diminished cardiac output, and inadequate end-organ perfusion. The American College of Surgeons (ACS) Advanced Trauma Life Support (ATLS) classifies hemorrhagic shock into four distinct classes based on physiological derangement in a standard 70 kg adult. The heart-rate and urine-output numbers below are the classic teaching values; the current ATLS manual describes trends (normal, increased, decreased) and adds base deficit and the need for blood products, so treat the numbers as approximations.
| Parameter | Class I | Class II | Class III | Class IV |
|---|---|---|---|---|
| Blood Loss (mL) | <750 mL | 750–1,500 mL | 1,500–2,000 mL | >2,000 mL |
| Blood Loss (% Blood Vol) | <15% | 15%–30% | 30%–40% | >40% |
| Heart Rate (bpm) | <100 | 100–120 | 120–140 | >140 |
| Blood Pressure | Normal | Normal | Decreased | Severely Decreased |
| Pulse Pressure | Normal / Widened | Decreased (Narrowed) | Decreased | Severely Decreased / Flat |
| Respiratory Rate (/min) | 14–20 | 20–30 | 30–40 | >35 |
| Urine Output (mL/hr) | >30 | 20–30 | 5–15 | Negligible |
| Mental Status | Slightly anxious | Mildly anxious | Anxious, confused | Confused, lethargic |
| Base Deficit (mEq/L) | 0 to −2 | −2 to −6 | −6 to −10 | ≤ −10 |
| Initial Resuscitation | Crystalloid | Crystalloid ± Blood | Blood Products + Crystalloid | Immediate MTP (1:1:1) |
Note
Narrowing of the pulse pressure (systolic minus diastolic blood pressure) is the earliest clinical hemodynamic sign of Class II shock. Circulating catecholamines increase systemic vascular resistance, selectively elevating diastolic blood pressure before systolic pressure falls.
Non-Hemorrhagic Hypovolemic Shock
Non-hemorrhagic volume loss stems from gastrointestinal fluid losses (severe vomiting, cholera, profuse secretory diarrhea), renal losses (osmotic diuresis, diabetic ketoacidosis, excessive loop diuretics), or massive cutaneous losses/third-spacing:
- Severe Thermal Burns: Resuscitation is guided by the Consensus Parkland formula: 4 mL × actual body weight (kg) × % Total Body Surface Area (%TBSA) burned (2nd and 3rd degree burns only) administered over the first 24 hours. Half of the total volume is infused over the first 8 hours from the time of burn injury, and the remaining half over the subsequent 16 hours. Balanced crystalloids (Lactated Ringer's) are required; Normal Saline precipitates profound hyperchloremic acidosis during large-volume burn resuscitation.
Damage Control Resuscitation (DCR) and Permissive Hypotension
Damage Control Resuscitation (DCR) is a structured trauma resuscitation paradigm designed to restore perfusion while avoiding the iatrogenic complications of traditional high-volume crystalloid resuscitation.
Core Tenets of DCR
- Immediate Hemorrhage Control: Direct pressure, tourniquets, pelvic binders, surgical exploration, or interventional radiology angioembolization.
- Minimization of Crystalloids: Avoiding large-volume crystalloid infusions (crystalloid fluids dilute clotting factors, cool the patient, induce endothelial glycocalyx shedding, and cause abdominal compartment syndrome).
- Permissive Hypotension: Maintaining systemic blood pressure below normal levels until surgical hemostasis is achieved.
- Target Parameters: Systolic blood pressure 80–90 mmHg (or mean arterial pressure 50–60 mmHg).
- Physiological Rationale: Elevated hydrostatic pressure dislodges newly formed platelet-fibrin plugs ("popping the clot") and accelerates hemorrhage. Permissive hypotension preserves minimal vital organ perfusion while preventing clot disruption.
Caution
Strict Contraindication in Traumatic Brain Injury (TBI): Permissive hypotension is absolutely contraindicated in patients with known or suspected severe TBI (Glasgow Coma Scale ≤8) or spinal cord injury. In brain injury, autoregulation of cerebral blood flow is abolished, and cerebral perfusion pressure (CPP = MAP - ICP) directly mirrors systemic blood pressure. A single episode of SBP <90 mmHg doubles trauma brain mortality. The Brain Trauma Foundation guidelines mandate maintaining SBP ≥100 mmHg (for patients 50–69 years) or SBP ≥110 mmHg (for patients 15–49 or ≥70 years) in TBI.
Massive Transfusion Protocol (MTP) and the PROPPR Trial
Massive transfusion is clinically defined as the transfusion of ≥10 units of packed red blood cells (PRBCs) within 24 hours, or the rapid replacement of >4 units of PRBCs within 1 hour in the presence of ongoing life-threatening hemorrhage.
Balanced 1:1:1 Transfusion Ratio
Rather than administering PRBCs alone followed by late clotting factor repletion, modern emergency resuscitation utilizes a fixed, pre-assembled ratio of blood products:
- 1 unit of Packed Red Blood Cells (PRBC)
- 1 unit of Fresh Frozen Plasma (FFP)
- 1 unit of Platelets (typically 1 apheresis unit or 6 pooled random-donor units per 6 PRBC units)
Landmark Evidence: The PROPPR Trial
The PROPPR trial (Pragmatic Randomized Optimal Platelet and Plasma Ratios, JAMA 2015) randomized 680 severely bleeding trauma patients to a 1:1:1 ratio versus a 1:1:2 ratio.
- The 1:1:1 group achieved anatomical hemostasis significantly faster (86% vs. 78%, p = 0.006).
- The 1:1:1 group demonstrated a significant reduction in 24-hour mortality from exsanguination (9.2% vs. 14.6%, p = 0.03).
- Although overall 30-day all-cause mortality did not reach statistical significance between groups, early balanced resuscitation halted fatal exsanguination without increasing pulmonary complications or thrombotic events.
Viscoelastic Testing in Trauma: TEG and ROTEM
Standard coagulation assays (PT/INR, aPTT) are performed on platelet-poor plasma at a standardized temperature (37°C), taking 45–60 minutes to process and failing to reflect in vivo platelet function, clot kinetics, or hyperfibrinolysis. Viscoelastic hemostatic assays—Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)—evaluate whole blood clot formation in real time within 10 to 15 minutes.
| Viscoelastic Phase | TEG Parameter (Normal) | ROTEM Parameter (Normal) | Coagulation Defect | Targeted Pharmacotherapy / Product |
|---|---|---|---|---|
| Clot Initiation | R-time (Reaction time: 5–10 min) | CT (Clotting Time: 100–240 sec) | Deficient clotting factors, severe hemodilution | Fresh Frozen Plasma (FFP) (10–15 mL/kg) or 4-Factor PCC |
| Clot Kinetics / Propagation | K-time (1–3 min); α-angle (53°–72°) | CFT (Clot Formation Time: 70–150 s); α-angle (65°–79°) | Deficient fibrinogen polymerization; weak thrombin burst | Cryoprecipitate (10 units or 2 pooled units) or Fibrinogen concentrate |
| Clot Strength | MA (Maximum Amplitude: 50–70 mm) | MCF (Maximum Clot Firmness: 50–72 mm) | Platelet hypofunction (80%) or low fibrinogen (20%) | Platelets (1 apheresis pack) ± Cryoprecipitate (if α-angle low) |
| Clot Lysis (Fibrinolysis) | LY30 (Clot lysis at 30 min: 0%–3%) | ML (Maximum Lysis: <15%) | Hyperfibrinolysis (accelerated plasmin breakdown) | Tranexamic Acid (TXA) IV loading bolus & infusion |
Tranexamic Acid (TXA) Resuscitation Protocols
Tranexamic acid is a synthetic lysine analogue that competitively inhibits the lysine-binding sites on plasminogen. By preventing plasminogen activation to plasmin, TXA halts plasmin-mediated fibrin degradation, stabilizing the hemostatic clot.
Dosing Regimen & Administration
- Loading Dose: 1 g IV infused over 10 minutes (rapid push over <5 minutes can cause severe transient arterial hypotension due to histamine release).
- Maintenance Infusion: 1 g IV infused continuously over 8 hours.
Evidence from the CRASH-2 Trial & The 3-Hour Time Window
The landmark CRASH-2 trial (Lancet 2010; n=20,211 adult trauma patients) demonstrated that TXA significantly reduced:
- All-cause mortality (14.5% vs. 16.0%; relative risk [RR] 0.91; p = 0.0035).
- Death due to bleeding (4.9% vs. 5.7%; RR 0.85; p = 0.0077).
Important
The 3-Hour Critical Rule: Subgroup analysis of CRASH-2 revealed that the efficacy of TXA is strictly time-dependent. When given within 1 hour of injury, TXA reduced the risk of death due to bleeding by 32% (RR 0.68). When administered between 1 and 3 hours, the risk reduction was 21% (RR 0.79). However, when TXA was administered greater than 3 hours after injury, it was associated with a statistically significant increase in death due to bleeding (4.4% vs. 3.1%; RR 1.44; p = 0.004). Therefore, TXA must NOT be initiated if more than 3 hours have elapsed since the traumatic injury.
Citrate Toxicity, Calcium Repletion, and Halting the Lethal Triad
Stored packed red blood cells, fresh frozen plasma, and platelets contain sodium citrate as an anticoagulant preservative. Citrate prevents clotting during storage by chelating free calcium ions (Ca²⁺).
Citrate Toxicity and Acute Hypocalcemia
During rapid massive transfusion, the rate of citrate infusion exceeds the metabolic clearance capacity of the liver, particularly in patients who are hypothermic, acidotic, or experiencing hepatic hypoperfusion. Citrate accumulates and binds circulating ionized calcium, causing precipitous hypocalcemia.
- Pathophysiological Consequences: Ionized calcium is an essential cofactor (Factor IV) in the assembly of the tenase and prothrombinase coagulation complexes. Severe hypocalcemia (iCa <1.0 mmol/L) induces refractory coagulopathy, impairs myocardial contractility, causes arterial vasodilation, prolongs the QTc interval, and triggers life-threatening dysrhythmias.
- Emergency Calcium Repletion Protocol:
- Target serum ionized calcium: >1.1–1.2 mmol/L.
- Empiric Administration Rule: Administer 1 to 2 g IV Calcium Chloride (or 3 g IV Calcium Gluconate) for every 4 units of blood products transfused.
- Calcium Chloride vs. Gluconate: 1 g of calcium chloride provides 13.6 mEq (272 mg) of elemental calcium, while 1 g of calcium gluconate provides 4.65 mEq (93 mg), so roughly 3 g of gluconate equals 1 g of chloride. Both ionize rapidly; the old claim that gluconate needs hepatic metabolism is a myth. Chloride is usually given through central or large, well-running access because extravasation causes tissue necrosis; gluconate is the safer peripheral choice.
The Lethal Triad of Trauma
The vicious cycle of trauma mortality consists of hypothermia, coagulopathy, and acidosis.
- Hypothermia (<35°C): Slows the kinetics of coagulation enzyme cascades and inhibits platelet activation. Every 1°C drop in core temperature reduces coagulation enzyme activity by 10%. All transfused fluids and blood products must pass through high-flow commercial fluid warmers, and active external warming blankets must be deployed immediately.
- Acidosis (pH <7.20, Base Deficit ≤ −6 mEq/L): Inactivates coagulation factors; at pH <7.20, factor Xa/Va prothrombinase activity drops by over 50%. Acidosis is corrected by restoring microvascular perfusion through hemostasis and RBC oxygen delivery, not by pushing sodium bicarbonate boluses.
- Coagulopathy: Dilutional coagulopathy is averted by initiating balanced 1:1:1 transfusion and replacing calcium aggressively.
A 28-year-old male arrives at the emergency department via EMS 75 minutes after suffering multiple gunshot wounds to the abdomen. He is pale, diaphoretic, and confused. Vital signs: blood pressure 82/50 mmHg, heart rate 138 bpm, and respiratory rate 28 breaths/min. Focused assessment with sonography in trauma (FAST) is positive for free intra-abdominal fluid. The massive transfusion protocol is activated. Regarding the administration of tranexamic acid (TXA) based on the CRASH-2 trial, which instruction is most appropriate?
Withhold TXA until a laboratory D-dimer and fibrinogen level confirm active systemic hyperfibrinolysis
Administer TXA 1 g IV infused over 10 minutes, followed by a continuous IV infusion of 1 g over 8 hours
Administer TXA 2 g as a rapid IV push over 1 minute to achieve immediate hemostatic peak levels
Administer TXA only if surgical laparotomy cannot be performed within the first 6 hours of injury
A 34-year-old female involved in a high-speed motor vehicle collision has received 8 units of packed red blood cells, 8 units of fresh frozen plasma, and 2 single-donor platelet units during emergency resuscitation for severe pelvic fractures. Her blood pressure is 86/48 mmHg, and her continuous ECG tracing demonstrates sudden widening of the QRS complex and prolongation of the QTc interval to 540 ms. Point-of-care arterial blood gas reveals an ionized calcium level of 0.72 mmol/L (normal range 1.15–1.33 mmol/L). Which pathophysiological mechanism and emergency management are correct?
Dilutional hypomagnesemia is the sole cause of the ECG abnormalities; administer 2 g of magnesium sulfate IV and repeat labs in 4 hours
Heparin contamination from the transfusion tubing caused acute hypocalcemia; administer protamine sulfate 50 mg IV immediately
Potassium release from stored red blood cells has competitively displaced calcium; administer intravenous regular insulin and dextrose
Sodium citrate preservative in the transfused blood products has chelated serum ionized calcium; administer 2 g of IV calcium chloride
Sections you finish are checked off in the contents.